Current and emerging EGFR therapies for glioblastoma-Reference-Cited by-同舟云学术

Current and emerging EGFR therapies for glioblastoma

Published:2018-01-02 Issue:1 Volume:39 Page:1-11
ISSN:1532-1819
Container-title:Journal of Immunoassay and Immunochemistry
language:en
Short-container-title:Journal of Immunoassay and Immunochemistry

Author:

Artene Stefan Alexandru¹,Tuţă Cristian¹,Dragoi Alexandra¹,Alexandru Oana²,Stefana Oana Purcaru¹,Tache Daniela Elise¹,Dănciulescu Maria Mihaela³,Boldeanu Mihai Virgil⁴,Siloşi Cristian Adrian⁵,Dricu Anica¹

Affiliation:

1. Department of Functional Sciences, University of Medicine and Pharmacy of Craiova, Craiova, Romania

2. Department of Neurology, “Bagdasar–Arseni” University of Medicine and Pharmacy Carol Davila, Bucharest, Romania

3. Department of Oncology, University of Medicine and Pharmacy of Craiova, Craiova, Romania

4. Department of Microbiology, University of Medicine and Pharmacy of Craiova, Craiova, Romania

5. Department of Immunology-Laboratory of Immunology, University of Medicine and Pharmacy of Craiova, Craiova, Romania

Funder

The Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) Romania

Publisher

Informa UK Limited

Subject

Medical Laboratory Technology,Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/15321819.2017.1411816

Reference58 articles.

1. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1)viasiRNA-induced cell death in glioblastoma

2. Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

3. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics

4. Biomarkers of glioblastoma multiforme

5. Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression;British Journal of Cancer;2024-09-12

2. Citrullinating enzyme PADI4 and transcriptional repressor RING1B bind in cancer cells;International Journal of Biological Macromolecules;2024-08

3. Exploring ncRNA-mediated regulation of EGFR signalling in glioblastoma: From mechanisms to therapeutics;Life Sciences;2024-05

4. Glioma Stem Cells—Features for New Therapy Design;Cancers;2024-04-19

5. Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review);Experimental and Therapeutic Medicine;2021-10-06